Levin Capital Strategies’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,000
| Closed | -$515K | – | 226 |
|
|
2023
Q4 | $515K | Buy |
24,000
+10,000
| +71% | +$215K | 0.06% | 120 |
|
|
2023
Q3 | $289K | Buy |
14,000
+6,500
| +87% | +$134K | 0.03% | 176 |
|
|
2023
Q2 | $221K | Buy |
+7,500
| New | +$221K | 0.03% | 191 |
|
|
2022
Q4 | – | Sell |
-9,500
| Closed | -$292K | – | 237 |
|
|
2022
Q3 | $292K | Buy |
9,500
+7,000
| +280% | +$215K | 0.04% | 150 |
|
|
2022
Q2 | $74K | Buy |
+2,500
| New | +$74K | 0.01% | 203 |
|